News by subject: HEALTH

Evaxion Biotech A/S ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced that the U.S. Food and Drug Administration ("FDA") determined that the Company may...

Samsung Bioepis Co., Ltd. today announced that Health Canada has approved HADLIMAtm (also known as SB5) - a citrate-free, high concentration (40 mg/0.4 ML) formulation of...

Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the Company will be presenting at the Biotech Showcase on Tuesday, January 10, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Time:...

Imagine ringing in the New Year more than 100 times in your lifetime. That is the reality for many Revera retirement home residents, and we can't help but marvel at their extraordinary human achievement - that of a long life well lived. To ring in...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180) and...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has submitted the Type C meeting request...

Acasti Pharma Inc. ("Acasti" or the "Company") , a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that preliminary topline results for its single-dose,...

Ontario joins British Columbia, Alberta, Quebec, New Brunswick, Nova Scotia, Saskatchewan, and the Northwest Territories in implementing a "switch" policy that changes coverage for specific biologic medicines.Biosimilar switch policies are an...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that the last patient has completed its...

Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2022 financial results and operational highlights. These results...

Curium, the world's leading nuclear medicine company, announced today that with the successful restarting of the BR2 research reactor in Belgium on 20 December, Curium's supply of molybdenum-99 (Mo-99) and iodine-131 is continuing as usual. This...

December 21, 2022 Amsterdam, the Netherlands ? Royal Philips today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics, following the voluntary recall notification/field safety notice*...

As 2022 comes to an end, Protein Industries Canada is celebrating the advancement of Canada's plant-based food and ingredient sector, and the achievement of significant milestones as an organization. "Over the past four years, Protein Industries...

Datacubed Health ("Datacubed"), a digital health technology company that supports hybrid and decentralized clinical trials, and Sterling Partners ("Sterling"), a prominent investment management firm, announced December 20, 2022, substantial...

Biogen Inc. announced that it has reached an agreement with Genentech, a member of the Roche Group, related to the commercialization and sharing of economics for glofitamab. Under the terms of the agreement, Biogen will have no payment obligations...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the completion of dosing in the XRX-OXY-101...

Wesana Health Holdings Inc. ("Wesana" or the "Company") , a data-driven life sciences company, today announced that Wesana Health Inc. ("WHI"), a subsidiary of the Company, has received an unsecured short-term loan in an aggregate principal amount of...

As Canada's premiers and the federal NDP ramp up the pressure on the Trudeau government, Health Coalitions across Canada are demanding that any increase in public health funding be used in the public interest and not be used to privatize health care....

This holiday season, California Prunes is presenting recipes from Quebec-based chef, Christopher Kassab, who has showcased the many ways to elevate your entertaining with the flavorful, under-the-radar superfood. While many are aware of the health...

Providence Therapeutics Holdings Inc. ("Providence"), a clinical-stage biotechnology company pioneering mRNA vaccines for infectious diseases and oncology, today announced that its new mRNA vaccine program for rabies post-exposure prophylaxis has...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a leader in specialty ketamine pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ketamine in the prevention of...

BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an exclusive Distribution Agreement with a European partner for a product that is used in oncology supportive...

A tobacco-free Quebec has been our collective goal. Quebec's smoking population continues to decline, reducing Quebecer's risk of serious illnesses caused by combustible tobacco. The Canadian Vaping Association (CVA) has opposed the taxation of...

Southern Alberta has a significant rate of critically ill and preterm births requiring the care of the neonatal intensive care unit (NICU). When these babies are born too sick, too early and too small, they are immediately transferred to the highly...

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is excited to announce a new collaboration with Associate...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that it will provide its drug candidate SPL026, an intravenous...

Avicanna Inc. ("Avicanna" or the "Company") , a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it will be initiating an...

Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it will host its Q4 and Full Year Fiscal 2022 earnings conference call and audio webcast on...

Alcohol was involved in more medical emergencies that sent young people to hospital emergency departments (EDs) than cannabis or opioids, according to a new study of 4,634 cases in three Canadian communities. In a four-year study of EDs in...

Glenora Park, Edmonton's newest and most prestigious retirement living residence, is open and welcoming new residents. ONE Properties, a privately owned, integrated real estate investment firm that develops and manages a range of high-quality...

MCI Onehealth Technologies Inc. ("MCI" or the "Company") , a clinician-led...

Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address addiction and mental health, is pleased to announce...

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy retrospective analysis comparing outcomes of patients treated with ECT-001 (UM171-expanded) Cell Therapy...

What: Ontario Health Coalition leader Natalie Mehra will be available to respond to the Ford government's denial and downplaying of the hospital crisis and failure to address it outside the Queen's Park south facing main entrance on Monday December...

What: Ontario Health Coalition leader Natalie Mehra will be available to respond to the Ford government's denial and downplaying of the hospital crisis and failure to address it outside the Queen's Park south facing main entrance on Monday December...

Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®) (STO:SOBI), announced today that...

The Ontario Health Coalition has tracked hospital cuts, closures, service closures and overcrowding for more than two decades and are experts in the history and scale of these events. The Coalition has never seen the crisis in our public hospitals...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, is pleased to announce that George Tziras, Chief Executive Officer and Dr. Carol...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce new proof of concept data demonstrating, in a...

The Ontario Health Coalition has tracked hospital cuts, closures, service closures and overcrowding for more than two decades and are experts in the history and scale of these events. The Coalition has never seen the crisis in our public hospitals...

The Sabin Vaccine Institute today honored two extraordinary scientists for their breakthrough vaccine research that changed the course of the COVID-19 pandemic, advanced public health, and saved countless lives. The 2022 Albert B. Sabin Gold Medal...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that treatment with...

A new study by Calgon Carbon Corporation ("Calgon Carbon"), a wholly owned subsidiary of Kuraray Co., Ltd. (TYO: 3405) ("Kuraray"), has provided a definitive response to a persistent question about the fate of PFAS during reactivation of activated...

Novel antibody, TB006, demonstrated improvements in cognition and function and was well tolerated in a one-month Phase 1b/2 trial in mild to severe Alzheimer's disease (AD) patientsTB006 also demonstrated improvements in PET and MR imaging,...

InterCure Ltd. (dba Canndoc) ("InterCure" or the "Company") is pleased to announce the withdrawal of a class action lawsuit against it (the "Regenera Lawsuit"). The Regenera Lawsuit was described in the Company's press release dated May 26, 2020...

Sweegen announced its strategic investment and partnership snapshot ahead of the FI Europe 2022, where it will exhibit zero sugar solutions in immersive food experiences, displaying consumers' favorite foods and beverages with zero sugar solutions in...

Nymox Pharmaceutical Corporation (the "Company") is pleased to announce today that a new formal submission has been made by the Company in Europe for Fexapotide Triflutate for the treatment of benign prostatic hyperplasia (BPH). The trademarked name...

The Canadian Association of Suicide Prevention (CASP) and the Canadian Suicide Prevention Coordinators Network (CSPCN) are pleased to announce that they have recently joined forces through a partnership that will strengthen collaborations among the...

Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch Spectronaut 17 today at the HUPO 2022 World Congress in Cancun, Mexico. Since its first release in 2003, Spectronaut has...

Biogen Inc. announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for review of tofersen, an investigational drug for the treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis...